Biểu đồ giá cổ phiếu ROIV
ROIV Tài chính
Roivant Sciences Ltd
$35.28
-0.28%
$-0.1
Tính đến ngày hôm nay:Jul 07, 10:24:10 GMT-4
Quay lại
Roivant Sciences Ltd (ROIV) Tài chính
Thống kê chính
Giá đóng cửa trước
$35.39
Giá mở cửa
$35.61
Phạm vi ngày
$35.07 - $35.61
Phạm vi 52 tuần
$10.7 - $35.28
Khối lượng
576.3K
Khối lượng trung bình
6.0M
Tỷ suất cổ tức
--
EPS (TTM)
-0.45
Vốn hóa thị trường
$25.3B
ROIV là gì?
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. The Company’s pipeline includes brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis and cutaneous sarcoidosis; IMVT-1402 and batoclimab, fully human monoclonal antibodies targeting FcRn in development across several IgG-mediated autoimmune indications; and mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease. The company also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business.
